VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 166 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $281,000 | -61.7% | 11,022 | -61.3% | 0.02% | -36.1% |
| Q1 2022 | $733,000 | -25.0% | 28,492 | +22.1% | 0.04% | -23.4% |
| Q4 2021 | $977,000 | +321.1% | 23,339 | +376.3% | 0.05% | +135.0% |
| Q2 2021 | $232,000 | -2.9% | 4,900 | +5.2% | 0.02% | -13.0% |
| Q1 2021 | $239,000 | +16.6% | 4,660 | -39.1% | 0.02% | +9.5% |
| Q4 2020 | $205,000 | -18.3% | 7,655 | +4.9% | 0.02% | -32.3% |
| Q3 2020 | $251,000 | – | 7,297 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |